The degradation of L-ascorbate (AsA) and its primary oxidation products, L-dehydroascorbate (DHA) and 2,3-Ldiketogulonate (2,3-DKG) were studied under physiological conditions. Analysis determined that L-erythrulose (ERU) and oxalate were the primary degradation products of ASA regardless of which compound was used as the starting material. The identification of ERU was determined by proton decoupled 13 C-nuclear magnetic resonance spectroscopy, and was quantified by high performance liquid chromatography, and enzymatic analysis. The molar yield of ERU from 2,3-DKG at pH 7.0 37³C and limiting O 2 , was s 97%. This novel ketose product of AsA degradation, was additionally qualitatively identified by gas-liquid chromatography, and by thin layer chromatography. ERU is an extremely reactive ketose, which rapidly glycates and crosslinks proteins, and therefore may mediate the AsA-dependent modification of protein (ascorbylation) seen in vitro, and also proposed to occur in vivo in human lens during diabetic and age-onset cataract formation. ß
Introduction
L-Ascorbate (AsA) serves as the primary water soluble antioxidant in cells [1] . AsA preferentially interacts with reactive oxygen species (ROS) generated during oxidative stress, thus protecting cell con-stituents from oxidative damage [2] . Recent interest in the potential toxicity of AsA [3^5] has focused attention on the primary oxidation product produced when AsA interacts with ROS, L-dehydroascorbate (DHA). Unlike AsA, DHA is both unstable in the absence of oxygen [6] , and is a reactive electrophile, which generates further reactive degradation products over time in solution [5] . These electrophilic products react with nucleophiles on proteins, specifically lysinyl and arginyl residues, resulting in structurally deleterious, non-enzymatic modi¢cations of proteins [7] . Tissues maintain a low concentration of DHA due to its reduction back to ASA by glutathione, both enzymatically and non-enzymatically [8] . However, there is an equilibrium level of DHA equivalent to V5% the AsA pool, which may rise 0925-4439 / 00 / $^see front matter ß 2000 Published by Elsevier Science B.V. All rights reserved. PII: S 0 9 2 5 -4 4 3 9 ( 0 0 ) 0 0 0 0 9 -0 Abbreviations: AsA, L-ascorbate ; DHA, L-dehydroascorbate ; 2,3-DKG, 2,3-L-diketogulonate; ERU, L-erythrulose ; ROS, reactive oxygen species; O 3 2 , superoxide anion; HLH, Human lens homogenates ; TLC, thin layer chromatography; HPLC, high performance liquid chromatography; GLC, gas-liquid chromatography; NMR, nuclear magnetic resonance * Corresponding author. Fax: +1-573-884-4100.
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www.elsevier.com/locate/bba after oxidative stress [9^11] . Increases in DHA degradation have been hypothesized to be involved in the etiology of a variety of diseases, including senile cataract [12] , aging [13] , diabetes [14] and Alzheimer's disease [15] . These diseases have all been associated with increases in ROS production and protein glycation. Hypothetically, increased ROS production in disease could lead to increased AsA oxidation, and therefore increased DHA accumulation and degradation to glycation-active products. It is therefore important to determine the products of AsA non-enzymatic degradation, as they may mediate the deleterious physiological e¡ects of DHA. Determination of the major non-enzymatic degradation product(s) of ASA at physiological conditions will also enhance the understanding of the catabolism of AsA in general. DHA rapidly hydrolyzes in solution at pH 7.0 to L-diketogulonate (2,3-DKG) [6] , which is very unstable and degrades further. Forty years after the ¢rst investigation in this area, it has been variously reported, that the non-enzymatic/catabolic degradation pathway of AsA leads through 2,3-DKG to CO 2 and L-xylose [16] , CO 2 and L-xylosone [17] , CO 2 , and Lxylonate plus L-lyxonate [18^20], oxalate and L-threonate [17, 19] , or oxalate and L-threose [21] . These divergent reports have prevented consensus on, and new investigations into, which degradation products of 2,3-DKG are produced under physiological conditions. Thus both the non-enzymatic and catabolic fates of vitamin C in vivo still remain in dispute. Recently 2,3-DKG concentrations have been shown to rise in oxidatively stressed human erythrocytes in vitro [22] , and in the lens of rats placed under diabetic stress [23] . High lenticular rates of 2,3-DKG degradation in rats were correlated with increased cataract formation in vivo [24] . Importantly, the half life of DHA in vivo may be as short as 2 min [25] with rapid production of 2,3-DKG. However the fate of 2,3-DKG was not determined in these studies. Our interest in the ultimate degradation product(s) responsible for the ascorbylation of lens proteins led us to reinvestigate the AsA degradation pathway. The in vitro fates of AsA and its oxidation products DHA and 2,3-DKG, were followed in a pH 7.0 bu¡er at 23 or 37³C, and in human lens extracts, using nuclear magnetic resonance (NMR) spectroscopy.
Materials and methods

Materials
L-Ascorbate, L-dehydroascorbate, and L-erythrulose (97%) were purchased from Aldrich, Milwaukee, WI. These were assayed for purity by 13 C-NMR, and were found to contain no detectable impurities. Additionally commercial ERU was assayed by proton NMR, further con¢rming its purity. L-[2-13 C]AsA and L-[3-13 C]AsA were purchased from Omicron Biochemicals, South Bend, IN and the white crystalline acids (99% 13 C) contained no impurities as determined by NMR, and melting point. NADH and sorbitol dehydrogenase (EC 1.1.1.14, from sheep liver) were purchased from Sigma, St. Louis, MO, as were all other reagents used in the analytical studies. Potassium L-2,3-DKG was synthesized from AsA exactly as described by [26] , and L-xylosone was prepared as reported in [27] . 3-Deoxyglucosone was synthesized by the method as described in [28] . Thin layer plates (Silica Gel 60 F 254 , 5U20 mm) were obtained from Alltech, Deer¢eld, IL.
Thin-layer chromatography
TLC was conducted on silica gel plates using the following irrigants: butanol^acetic acid^water (3:1:1, v/v, irrigant A) and acetonitrile^water^ace-tone^acetic acid (80:15:5:6, v/v, irrigant B). Plates were stained using 2% vanillin (in 5% H 2 SO 4 , 95% ethanol; spray 1), or 0.93% aniline (free base)^1.66% O-phthalic acid in wet butanol (90% n-butanol, 10%, water; spray 2), and heated at 120³C for 10^15 min for development.
High performance liquid chromatography
HPLC was carried out using a Phenomenenx Rezex-RNM-carbohydrate column (in the Na form), with dimensions of 300U7.8 mm. The run £ow rate was 0.6 ml/min, with dH 2 O as the mobile phase. Aliquots were taken from the reaction mixtures containing 0.1^0.2 M DHA or 2,3-DKG in 0.2^0.4 M phosphate bu¡er and diluted 1:4 with dH 2 O. To remove UV absorbing chromophores, 50 mg of activated carbon was added per ml of the mixture. Samples were then sterile ¢ltered through a 0.2-Wm sterile acrodisc (Gelman Sciences, Ann Arbor MI), yielding a clear sample eluant. The injection volume for each sample run was 250 Wl. The chromatogram was monitored at 278 nm, using a Kratos spectro£ow 773 UV detector.
Gas-liquid chromatography
GLC was performed using a Varian 3400 instrument in the split mode. Separations were done using a 25-m Quadex 001-Ov-17 capillary column with an i.d. 0.025 mm. Analysis of sugar derivatives was done with a hold time of 2 min after injection, followed by a 150^250³C temperature gradient at 10³C/ min. Reaction mixtures containing 2,3-DKG or sugar standards were prepared for chromatography by preparing the alditol acetate derivatives according to the method described in [21] .
Nuclear magnetic resonance spectroscopy
Proton decoupled 13 C-NMR spectra were acquired at 23 or 37³C on 1 ml samples of DHA, or 2,3-DKG, in potassium phosphate bu¡er, pH 7.0 prepared in 9:1, H 2 O:D 2 O. A Bruker DRX500 ( 13 C-unlabeled studies) or DRX300 ( 13 C-labeled studies) spectrometer were used to collect spectra. The acquisition parameters used were; sweep frequency 125.757 MHz; pulse duration 8.24 Ws (90³); interpulse delay 4.5 Ws; and 1.0 Hz line broadening. The number of scans and other data speci¢c to a particular experiment are reported in the ¢gure legends. All samples were run with 3-(trimethylsilyl)propionic-2,2,3,3-d 4 acid, sodium salt as the internal standard, with its signal set at 0.00 ppm.
Ultraviolet spectroscopy
A solution of commercial ERU (97%) was prepared quantitatively in dH 2 O and puri¢ed by HPLC. The fraction containing the sugar was dried at 4³C. This was dissolved in phosphate bu¡er, pH 7.0, and the absorbency constants were determined (V = 278 nm, A M = 30 L/M 31 cm 31 ) representing the n to Z* transition characteristic for ketones. Quanti¢cation of ERU in the HPLC chromatograms was done by relating the observed ERU peak area to a standard curve of area vs. concentration, prepared by chromatography of known amounts of commercial ERU.
Sorbitol dehydrogenase assay
A commercial enzyme solution was prepared by dissolving 2 mg of sorbitol dehydrogenase (6.3 U/ mg) in 2 ml of 0.2 M KPO 4 bu¡er, pH 7.0, and diluting with 8 ml of 1.25% BSA, prepared in the same bu¡er. The enzyme prepared in this manner was found to be stable for at least 1 week at 4³C. ERU was assayed within the range from 0.025^0.2 M in 0.1 M phosphate bu¡er, pH 7.0, containing 13^15 Wl of the BSA/enzyme solution (or the amount of enzyme needed to reduce 0.1 M D-fructose at a rate of V0.6 vA 340 /min). NADH was added at a level of 375 WM, and vA 340 followed for 1 min. Each assay was carried out in duplicate. The K m for commercial ERU reduction was 0.260 M ( þ 17.6 M), while V max was 707 nmol ml 31 min 31 ( þ 3.2 nmol ml 31 min 31 ). Kinetic parameters were determined according to [29] . The kinetics of the HPLC puri¢ed product of 2,3-DKG, matched those determined with commercial ERU to within experimental error.
Human lens homogenates
Human lenses were obtained from Missouri Lions Eye Tissue Bank, and Human lens homogenates (HLH) were prepared as previously described [30] , with 1 ml of bu¡er per lens. Donors were aged 304 0 years, and the protein concentration of the homogenate was determined to be 25 mg/ml by the method of Bradford [31] for kinetic studies. Homogenates were prepared to 50 mg/ml for 13 C-AsA studies, were 500 Wl homogenate is V1 human lens. All lens protein extracts were prepared in chelex-treated phosphate bu¡er, pH 7.0, and sterile ¢ltered before use. No homogenates were dialyzed.
Degradation incubations
Incubations of DHA and 2,3-DKG were routinely carried out in phosphate bu¡ers pH 7.0 at 23 or 37³C, and sterile ¢ltered before incubation or before analysis by NMR, HPLC, GLC, or TLC. 5 mM 13 C-AsA (1 ml) was oxidized with ascorbate oxidase 20 U in 0.2 M phosphate bu¡er, pH 7.0, for 15 min. The enzyme was the rapidly removed by ultracentrifugation, and 500 Wl of the labeled DHA diluted to 2.5 mM for NMR with 400 Wl dH 2 O and 100 Wl D 2 O. Initial spectra showed only signals of DHA and 2,3-DKG.
SDS-PAGE
Gel electrophoresis of proteins cross-linked by sugars was conducted under reducing conditions as described by Laemmli [32] . All sugars were at a concentration of 10 mM and were incubated with 6 mg/ ml calf lens proteins for 5 days at 37³C, then diluted and assayed for crosslinking by SDS-PAGE.
Kinetics and 13 C-NMR studies in human lens homogenates
The NADH-dependent reduction of ERU by HLH (prepared as in Section 2.8 except in 0.05 M potassium phosphate bu¡er, pH 7.0) was studied with ERU and L-[3-13 C]-DHA/DKG (prepared as in Section 2.9) as starting materials. Assays of ERU were done within the range from 2.5 to 50 mM. NADH (0.425 mM) was preincubated for 2^3 min with 50 Wl HLH, which had been diluted with 300 Wl of bu¡er. All assays of ERU were done at a total volume of 1 ml and the decrease at A 340 was followed after the addition of ERU. Each data point was done in duplicate and kinetic parameters determined as in Section 2.7, over the ¢rst 2 min. The K m for reduction of ERU was 21.3 mM ( þ 2.5 mM), while V max was 66.2 nmol ml 31 min 31 ( þ 3.2 nmol ml 31 min 31 ). Studies to determine the e¡ect of varying the NAD /NADH ratio on ERU reduction were done similarly as in determination of kinetic constants. However, at the start [NADH] was 0.37 mM, while [NAD ] was varied from 0 to 1.5 mM. ERU was added to start the reduction at 0.020 M for all assays. In the determination of the e¡ects of D-sorbitol on ERU reduction both [NADH] 0.37 mM and [ERU] 0.15 mM were the same in all assays, while [D-sorbitol] was varied from 0 to 0.45 M.
NMR studies on the reduction of ERU by HLH, were done using 0.5 ml of oxidized L-[3-13 C]AsA prepared as in Section 2.9. This was added to 0.5 ml of HLH prepared as in Section 2.8. Therefore, in these studies, 0.5 ml HLE is equivalent to V1 human lens.
Results
3.1. Oxalate and ERU are the products of 2,3-DKG degradation 2,3-DKG degradation was followed continuously by 13 C-NMR over 40 h at 23³C under essentially anaerobic conditions (Fig. 1) . The initial NMR spectrum of 2,3-DKG with C1^C6 resonances at 176.98, 97.87, 97.28, 77.05, 71.07 and 64.92 ( Fig. 1a ) corresponded to the reported proton decoupled spectra [33] . After 24 h, the 2,3-DKG signals had decreased substantially and ¢ve new resonances appeared at 215.23, 176.01, 78.74, 68.74 and 65.80 ppm. (Fig.  1b ). After 40 h of incubation, the degradation was nearly complete (Fig. 1c ) with the production an apparent ¢ve carbon product in nearly quantitative yields. The identi¢cation of two products, ERU with four carbons at 215.23, 78.74, 68.74, and 65.80 ppm, and oxalate with two carbons (one resonance), was con¢rmed by spiking the NMR tube at the end of the degradation (Fig. 1d ) with ERU ( Fig. 1e) . A similar spike with authentic oxalate con¢rmed the peak at 176.01 ppm as oxalate (data not shown). The production of ERU was also detected by TLC (Table 1 ). This analysis agreed with the NMR results, showing that the 2,3-DKG degradation product consistently migrated with the ERU standard in two solvent systems. In irrigant A, ERU was clearly separated from L-threose, a previously proposed product. GLC analysis showed that both erythritol and threitol were formed following NaBH 4 reduction of the 2,3-DKG degradation product ( Table 2 ). Since both alditols were produced by the reduction of the product, the 2,3-DKG degradation product could again be identi¢ed as ERU.
ERU is produced quantitatively from both DHA and 2,3-DKG
The degradation of DHA was similarly followed by 13 C-NMR. As shown in Fig. 2 , the rate pro¢le for production of 2,3-DKG from DHA and that for the sequential degradation of 2,3-DKG to ERU, were obtained at pH 7.0 and 37³C. ERU was still the ¢nal product with DHA as the starting material, and was detected after 1.5 h of the DHA incubation. To quantify the yield of ERU from 2,3-DKG, we developed an HPLC method for its separation and detection. The chromatogram (Fig. 3) shows that the 2,3-DKG degradation product eluted with authentic ERU as con¢rmed by spiking the reaction with the commercial compound. The product was quanti¢ed by HPLC and UV-VIS spectroscopy (Fig. 4) . The ketose could be detected after only 1 h by this method. At the end of the 2,3-DKG incubation, the ketose accounted for 63.5% of the initial molar amount of 2,3-DKG, and the half-life (t 1a2 ) of ERU under these conditions (see inset) was determined to be V32 h. Considering both the production of ketose from 2,3-DKG and the t 1a2 of the ketose, the molar [20] . Aliquots from a degradation of 0.2 M L-2,3,-DKG in 0.4 M phosphate bu¡er, pH 7.0, 23³C, were reduced with NaBH 4 to alditol acetates before GLC analysis as in [20] . percentage of 2,3-DKG which was generated as ERU was estimated to be s 97%. An enzymatic assay using sorbitol dehydrogenase was performed on the HPLC fraction containing the product. Since this enzyme recognizes only the L-enantiomer of ERU [34, 35] , the NADH-dependent reduction of the HPLC eluant con¢rmed that it had retained the Lstereochemical con¢guration of the progenitor molecule L-2,3-DKG. Additionally, the kinetics of the enzymatic reduction of the 2,3-DKG product matched those obtained with commercial ERU (see Section 2.7). The single predicted product L-threitol (data not shown), also con¢rmed that the peak originally contained solely ERU.
ERU is the product of AsA degradation under non-oxidative conditions; L-threonic acid is produced under oxidative conditions
We next tested whether ERU could be produced from AsA. The degradation of L-[2-13 C]AsA and L-[3-13 C]AsA were followed after oxidation with ascorbate oxidase, which produces the products DHA and H 2 O from ascorbate and O 2 , in a chelex-treated phosphate bu¡er, at 23³C. The use of labeled AsA allowed the analysis of the degradation pathway by NMR at more physiological concentrations of AsA oxidation products. The results seen in Fig. 5 , clearly show that the major products after 12 h, are oxalate ( Fig. 5 , upper panel) from L-[2-13 C]AsA. Concomitantly ERU production ( Fig. 5 , lower panel) from L-[3-13 C]AsA is seen. In both cases the major signal after 2 h is that of 2,3-DKG ( 13 C-2, at 97.87 ppm, 13 C-3 at 97.28 ppm), which rapidly and quantitatively became only the signal for oxalate at 176.01 ppm (upper panel), and the C-1 signal of ERU at 68.74 ppm (lower panel). In both spectra, unidenti-¢ed intermediates can readily be detected. These results suggest that the mechanism by which oxalate and ERU are produced is via a carbon^carbon bond scission between C2, and C3 of 2,3-DKG, or an intermediate produced from 2,3-DKG Having established 2,3-DKG as the progenitor of ERU, we questioned why this ketose had not been found previously in AsA degradation studies, since it was the only product seen in our studies. H 2 O 2 (the product of AsA oxidation) was incubated with 2,3-DKG for 2 h (Fig. 6 ) in a phosphate bu¡er which had not been treated with chelex. The resulting NMR spectrum of the reaction clearly shows L-threonate as the major product (numbers are shown above the four signals of threonate), and a strong HCO 3 3 signal is also seen along with several uniden-ti¢ed acid signals. In this experiment, no ERU was detected. This suggest that H 2 O 2 produced by AsA oxidation, can oxidize 2,3-DKG preventing the formation of ERU.
ERU crosslinks lens protein
We tested the protein crosslinking ability of ERU to determine if it could account for the reported AsA-dependent modi¢cation of protein [5] . As seen in Fig. 7 , ERU crosslinked bovine lens proteins to a greater extent than the previously proposed glycation-active sugars glucose, fructose, or 3-deoxyglucosone after 4 days of incubation. This was primarily indicated by the large amount of high molecular weight aggregates that did not enter the resolving gel.
Human lens e¡ectively reduces ERU to L-threitol
Since ERU production during AsA catabolism would be potentially deleterious, we studied the capacity of HLH to reduce ERU to the tetritol. As determined (see Section 2.11) lens contains V1.33 U of NADH-dependent activity towards ERU as a substrate. The kinetic parameters were very similar to those found for the reduction of ERU by puri¢ed human sorbitol dehydrogenase [36] . We next evaluated the activity pro¢le over physiological ratios of NAD /NADH known to exist in the lens [37] . As can be seen ( Fig. 8, upper panel) even at the most inhibitory ratio of NAD /NADH of 4:1 the reductive activity was still V75% of that in the absence of NAD . The e¡ects of varying the ERU/Dsorbitol ratio were more signi¢cant. At a ratio of 1:12 the activity was inhibited V50%, (Fig. 8, lower  panel) .
Finally, we used 13 C-NMR to study the reduction of ERU by HLH. The homogenate slowly reduced ERU to L-threitol (65.60 ppm) using only the NADH present in the HLH (Fig. 9, upper panel) . As calculated from relative signal intensities of C1 of ERU and C1 of L-threitol, the breakdown of the entire 2.5 Wmol of 2,3-DKG over 6 h (V7 nmol min 31 ), is met by a corresponding reduction rate of V1.1 nmol min 31 and a total of V400 nmol of Lthreitol. At 14 h, V600 nmol of L-threitol were produced. Since human lens contains only 51^210 nmol of NADH [37] , the reduction rate is clearly limited by the availability of endogenous NADH, and the recycling of NAD to NADH. However, in the presence of excess of 5.0 Wmol added NADH, the tremendous capacity of the lens to reduce the 2.5 Wmol of ERU produced from 2,3-DKG is apparent ( Fig. 9 , lower panel). Even at a £ux rate equivalent to the turnover of the entire physiological level of 2.5 Wmol of AsA in only 4 h, little ERU can be detected and the C3 resonance of 2,3-DKG is converted to the C1 of L-threitol rapidly.
Discussion
ERU is the major product of the non-oxidative degradation of DHA, and 2,3-DKG. To our knowledge, this ketose product, which is formed in v 97% yield from 2,3-DKG, has not been previously reported. The in vitro degradation of AsA has been studied extensively under a variety of conditions to determine the fate of AsA oxidation products, both in solution, and in tissue homogenates. From these previous studies, an astounding variety of degradation/catabolic products of vitamin C have been reported. The conditions of these studies were primarily oxidative, owing to the need to initially oxidize AsA with O 2 to initiate the subsequent degradation. The reaction of H 2 O 2 , (the ignored product of AsA oxidation to DHA), with DHA and 2,3-DKG during their degradative fates has not been generally considered. Since many of the studies on the degradation and catabolism of AsA have been carried out in bu¡ers containing Fe 3 and Cu 2 impurities [38] , hydroxyl radical would be generated in signi¢cant amounts from the H 2 O 2 product by the Fenton reaction [39] . It has been determined that H 2 O 2 and DHA react directly at pH 7 to produce L-threonate and oxalate [40] quantitatively. Importantly, these products are among the reported catabolic metabolites of AsA [17, 19] . It is essential to emphasize that no L-threonate can be produced from DHA or 2,3-DKG without their oxidation. In addition, it is well established that H 2 O 2 reacts with 2-keto aldonic acids such as 2,3-DKG with sequential decarboxyla- tion of C1 and C2 [41] . This oxidation could account for the numerous reports of CO 2 , and the ¢ve carbon or four carbon sugar acid products seen in ascorbate degradations. The known e¡ect of hydroxyl radical production on sugars is to cause oxidative fragmen-tation [41] , with production of a variety of products, which may also have been erroneously reported as AsA catabolic products.
Our results support the hypothesis that two major AsA degradation pathways exist at physiological pH, one oxidative, and the second non-oxidative (see Scheme 1) . Central to the determination of which pathway predominates is the oxidative status of the milieu during 2,3-DKG degradation. In the presence of high concentrations of H 2 O 2 , 2,3-DKG produces L-threonate, oxalate, and CO 2 . In the absence of H 2 O 2 , s 97% ERU and oxalate are produced. The autoxidation of AsA in the absence of metal ions to L-threonolactone and oxalate has been recently reported by Miyake et al. This new pathway proceeds independent of DHA, but concomitant with the DHA-dependent pathway. Though potentially important, DHA was still the major product ( s 85%) even during AsA autoxidation to L-threonolactone and oxalate [42] .
Only a few studies have been done on the nonoxidative degradation of AsA at physiological conditions. In two such studies, ERU has been previously detected, but misidenti¢ed. Kang et al. [17] assessed the 13 C-NMR spectrum of the major DHA degradation product as L-xylosone (a 5-carbon product), when it clearly shows both ERU and oxalate. Also their spectrum does not correspond to the published spectra of L-xylosone [27] . Lopez and Feather [21] detected a tetrose produced in high yield in AsA, DHA and 2,3-DKG degradations. However, they misidenti¢ed it as L-threose, using a TLC solvent system, which did not adequately separate erythrulose and threose (see Table 1 , irrigant B).
Although none of our incubations were under strictly anaerobic conditions, our determination of the non-oxidative degradation pathway of AsA was dependent on several factors. First, the use of DHA and 2,3-DKG eliminated production of H 2 O 2 during the obligatory oxidation of AsA. Additionally, in each case, dissolved O 2 was insigni¢cant (V0.2 mM), because the concentration of DHA, or 2,3-DKG (0.1^0.2 M) were three orders of magnitude of greater than O 2 . We used ascorbate oxidase when con¢rming ERU production from AsA, which prevented the production of H 2 O 2 during the oxidation of ascorbate (the products of ascorbate oxidase are H 2 O and DHA). The use of chelex-treated bu¡ers reduced participation of the Fenton reaction in the studied degradation pathway. These conditions more closely re£ect those in vivo under which DHA and 2,3-DKG would degrade, namely in an environment with no free metals, and in low levels of H 2 O 2 due to its rapid endogenous detoxi¢cation by the antioxidant enzymes catalase and glutathione peroxidase. However although we do not know which pathway operates in vivo, the discovery of the non-oxidative pathway and its novel product ERU is signi¢cant, and may be important to the ¢nal determination of AsA catabolism.
We have shown that the major non-oxidative degradation product of AsA under physiological conditions is ERU. The ketose should be very reactive towards protein amino groups, since (by NMR) ERU appears in solution to exist nearly 100% in the free carbonyl form. Sugar reactivity towards protein amino groups has been strongly correlated with the percentage of free carbonyl of a particular monosaccharide in solution [43, 44] . Therefore, ERU is implicated as the species responsible for the faster and greater extent of protein crosslinking seen in incubations of AsA and protein, compared to similar incubations to those with using glucose [5] . The probability that ERU mediates AsA-dependent crosslinking is also argued by the relative half-lives of the AsA degradation products under conditions similar to those used in protein crosslinking studies (see Figs. 2 and 3) . With a half-life of V32 h in phos- Scheme 1. phate ERU based on structural considerations, should also be much more reactive than the shortlived DHA or 2,3-DKG with protein nucleophiles. This is especially true since DHA and 2,3-DKG are predominantly in unreactive hydrated and cyclic forms in solution. In addition to protein crosslinking, ERU produces more O 3 2 upon glycation than other proposed glycators [45] , which would increase its potential toxicity.
ERU may be a previously unidenti¢ed catabolite of AsA in vivo. We have determined that human lens has substantial NADH-dependent sorbitol dehydrogenase reductive activity for this ketose producing, NAD and L-threitol. The kinetics of ERU reduction, production of the product L-threitol, and the inhibition of reduction by D-sorbitol support both the identi¢cation of the reductive activity as that of lens sorbitol dehydrogenase, and further verify the product of 2,3-DKG degradation as ERU. We have shown that given a supply of NADH human lens has the capacity to prevent the accumulation of ERU, even at rapid rates of 2,3-DKG degradation.
Therefore ERU may be the progenitor of lens Lthreitol, a metabolite whose origin is still unknown [46] , and may originate from AsA catabolism. Additionally, a role for sorbitol dehydrogenase in reduction and detoxi¢cation of ERU could associate increased AsA oxidation and catabolism with the complications resulting from altered sorbitol pathway function. The fate of lenticular threitol is unknown; however, increased polyol production has been strongly implicated in cataract formation and diabetic complications.
